NASDAQ:BNR

Burning Rock Biotech Earning Date

USA |NASDAQ |USD

BNR Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 18, 2021 Sep 2021 $-0.25 $-0.30 $-0.19
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 18, 2021 Sep 2021 $19.98M $127.28M $123.88M

Burning Rock Biotech's next earnings date is Thursday, Nov 18, 2021 for the fiscal quarter ending Sep 2021.

BNR Earnings Date & History Chart

BNR Earnings & Revenue Forecast

BNR Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $-0.25 $-0.25 $-0.25
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-0.91 $-1.09 $-0.59
Dec 2022 3 $-0.75 $-1.07 $-0.32

BNR Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-0.25 $-0.19 $-0.19
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-0.91 $-0.62 $-0.69
Dec 2022 0 / 0 $-0.75 $-0.47 $-0.58

BNR Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 1 $20.69M $20.69M $20.69M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $77.97M $77.36M $78.53M
Dec 2022 4 $110.97M $92.79M $133.85M

BNR Earnings Date & Revenue History

BNR Earnings History

|
Show More
Show More

BNR Revenue History

|
Show More
Show More

Burning Rock Biotech Next Earnings Date & Report

BNR Next Earnings Date & Report Preview: Sep 2021 (FQ)

BNR's next earnings date is Thursday, Nov 18, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 1 analysts, the average EPS estimation for Burning Rock Biotech's next quarterly earnings is $-0.25, with a low EPS estimation of $-0.25, and a high estimation of $-0.25.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.25, the last 2 month trend is $-0.21, and the 3 month trend is $-0.21.

Based on 1 analysts, the average revenue estimation is $19.98M, with a low revenue estimation of $19.98M, and a high estimation of $19.98M.

Burning Rock Biotech Previous Earnings Dates & Reports

BNR Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Burning Rock Biotech's previous earnings date was Aug 31, 2021 for its fiscal quarter ended Jun 30, 2021.

BNR's earnings per share (EPS) was $-0.30, missing the consensus analysts forecast of $-0.15 by -107.52%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 17.87%, and higher than the same period a year before (Jun 2020) by -21.42%.

Revenues were $127.28M, better than the forecast of $21.41M by 494.48%, up by 19.37% from the previous quarter , and up by 18.98% from the same period last year.

The company reported a net income of $-203.66M.

Free cash flow for the quarter was $-119.00M , compared to $-113.14M last quarter and $61.12M a year before.

BNR ended the quarter with $135.58M in total debt, a decrease of -7.18% compared to the previous quarter, and an increase of 152.29% compared to the same quarter a year before.

BNR Previous Earnings Date & Report Recap: Dec 2020 (FY)

Burning Rock Biotech's previous annual earnings date was Mar 11, 2021 for its fiscal year ended Dec 31, 2020.

BNR's earnings per share (EPS) was $-0.80.

Revenues were $429.90M, better than the forecast of $64.81M by 563.33%, and up by 12.64% from previous year's revenue.

The company reported a net income of $-407.24M.

Burning Rock Biotech reported a free cash flow of $-153.08M for its fiscal year, compared to $-273.77M a year ago.